Understand the source comparison
Absorption, Bioavailability, and the Oral vs Liposomal Divide
Oral glutathione has historically faced scepticism because the tripeptide (glutamate-cysteine-glycine) can be broken down by peptidases in the gut before absorption. A 2014 study in the European Journal of Nutrition tested this directly: participants received
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Oral glutathione has historically faced scepticism because the tripeptide (glutamate-cysteine-glycine) can be broken down by peptidases in the gut before absorption. A 2014 study in the European Journal of Nutrition tested this directly: participants received 500mg of reduced glutathione orally, and researchers measured both plasma GSH and intracellular GSH in peripheral blood mononuclear cells (PBMCs. The immune cells). Results: plasma GSH increased by 30–35% at 60 minutes, and PBMC GSH increased by 20–25% at 90 minutes. The tripeptide does survive digestion in significant amounts. But not all of it.
- Liposomal glutathione addresses this by encapsulating GSH in phospholipid bilayers that protect it from enzymatic degradation and facilitate direct cellular uptake. A head-to-head trial published in Redox Biology compared 500mg liposomal GSH vs 500mg standard GSH vs placebo. Liposomal delivery increased intracellular GSH by 40–50% vs 20–25% for standard oral. The trade-off: liposomal formulations cost 3–5× more per dose. For immune support specifically, the question is whether that 20–25% difference in uptake translates to measurably better immune outcomes. And the data doesn't clearly support it. Both forms restore immune cell GSH to baseline; liposomal just does it faster.
- Timing matters more than form. Immune cells experience their highest oxidative stress during active infection or intense exercise. Dosing glutathione 30–60 minutes before anticipated immune challenge (pre-workout, before exposure to infection, during viral prodrome) positions peak plasma GSH to coincide with peak cellular demand. Split dosing. 500mg morning, 500mg evening. Maintains more stable intracellular levels than 1000mg once daily.